Immunic IMUX
NASDAQ IMUX
$8.07 -0.57 (-6.57%)
As of: Oct 2, 2026 · 11:38 AM EDT

Immunic (IMUX) Accumulated Depreciation (2013 - 2015)

Updated

Immunic (IMUX) posted Accumulated Depreciation of $7.36 million for Q2 2015, up 16.8% from $6.3 million a year earlier and up 4.1% from the prior quarter.

Analysis

Immunic (IMUX) Accumulated Depreciation (2013 - 2015) Analysis & Trends

At the end of FY2014, Immunic's Accumulated Depreciation came in at $6.78 million, up 17.8% from FY2013.

  • In prior years, Immunic's Accumulated Depreciation was $5.76 million in FY2013.
  • On a year-over-year basis, Accumulated Depreciation has increased in each of the last three quarters.
  • According to Business Quant data, Accumulated Depreciation for the three prior quarters was $7.07 million (Q1 2015), $6.78 million (Q4 2014) and $6.61 million (Q3 2014).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Immunic 395.38 Mn 395.38 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 7.36 Mn
Mar 31, 2015 7.07 Mn
Dec 31, 2014 6.78 Mn
Sep 30, 2014 6.61 Mn
Jun 30, 2014 6.30 Mn
Mar 31, 2014 6.05 Mn
Dec 31, 2013 5.76 Mn
API Access

Immunic Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=IMUX&period=max&api_key=YOUR_API_KEY